Pnc Financial Services »

Revance Therapeutics shares owned by Pnc Financial Services

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Pnc Financial Services from 13F filings

Historical chart of Pnc Financial Services investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Pnc Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Pnc Financial Services

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.1k 243 8.79
2023-09-30 $3.5k 308 11.47
2023-06-30 $11k 429 25.31
2023-03-31 $21k 650 32.21
2022-12-31 $12k 650 18.46
2022-09-30 $13k 472 27.23
2022-06-30 $7.0k 472 14.85
2022-03-31 $9.3k 472 19.80
2021-12-31 $67k 4.1k 16.39
2021-09-30 $14k 485 28.78
2021-06-30 $14k 485 28.78
2021-03-31 $14k 485 28.78
2020-12-31 $4.2k 165 25.64
2020-09-30 $4.2k 165 25.64
2020-06-30 $4.2k 165 25.64
2020-03-31 $1.6k 132 11.90
2019-12-31 $1.6k 132 11.90
2019-09-30 $0 48 0.00
2019-06-30 $0 48 0.00
2019-03-31 $0 48 0.00
2018-12-31 $0 48 0.00
2018-09-30 $2.0k 48 41.67
2018-06-30 $2.0k 48 41.67
2018-03-31 $2.0k 48 41.67
2017-12-31 $2.0k 48 41.67